Using a specific inhibitor of p38 MAP kinase, Du et al. have shown an important role of MAP kinase in the development of early stages of diabetic retinopathy, and the mechanism appears to be via regulation of inflammation in the retina [38]. This evidence concerns the gene MAPK14 and diabetic retinopathy.